Advanced search
Start date
Betweenand

Genetic polymorphisms of matrix metalloproteinases in resistant hypertension

Grant number: 12/23608-1
Support Opportunities:Regular Research Grants
Duration: January 01, 2014 - March 31, 2016
Field of knowledge:Health Sciences - Medicine - Medical Clinics
Principal Investigator:Gabriel Forato Anhê
Grantee:Gabriel Forato Anhê
Host Institution: Faculdade de Ciências Médicas (FCM). Universidade Estadual de Campinas (UNICAMP). Campinas , SP, Brazil
Associated researchers:Vanessa Fontana

Abstract

Resistant hypertension (RH) is characterized by high blood pressure in spite of concurrent use of three antihypertensive agents of different classes, combined at optimal doses and including a diuretic. Indeed, RH includes patients with controlled blood pressure using four or more agents. Resistant hypertensive patients have an unfavorable prognostic and the morbidity and mortality occur in consequence of the high prevalence of target-organ damage in these patients, including left ventricular hypertrophy and arterial stiffness. Metalloproteinases (MMPs) are a family of enzymes that degrade extracellular matrix proteins and are involved in cardiovascular remodeling related to target-organ damage in cardiovascular diseases, including hypertension (HT). Several studies in experimental models and in humans showed increased levels of MMPs-2 and -9 in HT. Furthermore, increased levels of MMP-9 were described as predictors of cardiovascular mortality. MMP-9 has an important role in inflammatory pathways. However, there is no study in resistant hypertension showing the role of MMPs in target-organ damage in this group of patients. The aim of this study is to evaluate the association of the levels and activity of MMP-2 and -9 and their inhibitors, TIMP-1 and TIMP-2, and how the polymorphisms in these two enzymes (MMP-2 -1575G>A; MMP-2 -1306C>T; MMP-2 -735C>T; MMP-9 -1562C>T; MMP-9 R279Q e MMP-9 R668Q) affect the left ventricular hypertrophy, arterial stiffness of the RH and HT diseases, as the presence of obstructive sleep apnea and lack of blood pressure control. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
VERSUTI RITTER, ALESSANDRA MILENI; DE FARIA, ANA PAULA; BARBARO, NATALIA; SABBATINI, ANDREA RODRIGUES; CORREA, NATHALIA BATISTA; BRUNELLI, VERIDIANA; AMORIM, RIVADAVIO; MODOLO, RODRIGO; MORENO, HEITOR. Crosstalk between obesity and MMP-9 in cardiac remodelling -a cross-sectional study in apparent treatment-resistant hypertension. BLOOD PRESSURE, v. 26, n. 2, p. 122-129, . (12/23608-1)
CORREA, NATHALIA BATISTA; DE FARIA, ANA PAULA; RITTER, ALESSANDRA M. V.; SABBATINI, ANDREA RODRIGUES; ALMEIDA, AURELIO; BRUNELLI, VERIDIANA; CALHOUN, DAVID A.; MORENO, HEITOR; MODOLO, RODRIGO. A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, v. 10, n. 6, p. 510-516, . (12/23608-1)
RITTER, ALESSANDRA M. V.; DE FARIA, ANA PAULA; BARBARO, NATALIA R.; SABBATINI, ANDREA R.; CORREA, NADIALIA BATISTA; BRUNELLI, VERIDIANA; FATTORI, ANDRE; AMORIN, RIVADAVIO; MODOLO, RODRIGO; MORENO, HEITOR. The rs243866/243865 polymorphisms in MMP-2 gene and the relationship with BP control in obese resistant hypertensive subjects. Gene, v. 646, p. 129-135, . (12/23608-1)

Please report errors in scientific publications list using this form.
X

Report errors in this page


Error details: